标题
Approach to the Patient With Treatment-resistant Acromegaly
作者
关键词
-
出版物
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume -, Issue -, Pages -
出版商
The Endocrine Society
发表日期
2022-01-29
DOI
10.1210/clinem/dgac037
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Predictors for Remission after Transsphenoidal Surgery in Acromegaly: A Dutch Multicenter Study
- (2021) Eva C Coopmans et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY
- (2021) Maria Fleseriu et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Fractionated radiotherapy and radiosurgery in acromegaly: analysis of 352 patients from the German Acromegaly Registry
- (2020) U J Knappe et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study
- (2020) Christopher S Graffeo et al. NEUROSURGERY
- T2-signal intensity, SSTR expression, and somatostatin analogs efficacy predict response to pasireotide in acromegaly
- (2020) Eva C Coopmans et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Cost-Effectiveness and Efficacy of a Novel Combination Regimen in Acromegaly: A Prospective, Randomized Trial
- (2020) Vivien Bonert et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Patients with acromegaly might not be at higher risk for dopamine agonist-induced impulse control disorders than those with prolactinomas
- (2020) Hande Mefkure Ozkaya et al. GROWTH HORMONE & IGF RESEARCH
- How to Position Pasireotide LAR Treatment in Acromegaly
- (2019) Eva C Coopmans et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pegvisomant improves Glucose Metabolism in Acromegaly: a meta-analysis of prospective interventional studies
- (2019) Tiziana Feola et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
- (2019) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs
- (2018) Atsuko Kasajima et al. HUMAN PATHOLOGY
- Efficacy and Safety of switching to Pasireotide in Acromegaly Patients controlled with Pegvisomant and Somatostatin Analogues: PAPE extension study
- (2018) Ammar Muhammad et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A Consensus Statement on acromegaly therapeutic outcomes
- (2018) Shlomo Melmed et al. Nature Reviews Endocrinology
- Long-term treatment with pegvisomant: observations from 2090 acromegaly patients in ACROSTUDY
- (2018) Michael Buchfelder et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- In Vitro Head-to-Head Comparison Between Octreotide and Pasireotide in GH-Secreting Pituitary Adenomas
- (2017) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy and Safety of Switching to Pasireotide in Patients With Acromegaly Controlled With Pegvisomant and First-Generation Somatostatin Analogues (PAPE Study)
- (2017) Ammar Muhammad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AIP and the somatostatin system in pituitary tumours
- (2017) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Long-Term Endocrine Outcomes Following Endoscopic Endonasal Transsphenoidal Surgery for Acromegaly and Associated Prognostic Factors
- (2017) Harish Babu et al. NEUROSURGERY
- Management of Hyperglycemia in Patients With Acromegaly Treated With Pasireotide LAR
- (2016) Susan L. Samson DRUGS
- Treatment with high doses of pegvisomant in 56 patients with acromegaly: experience from ACROSTUDY
- (2016) Aart Jan van der Lely et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Pasireotide for the treatment of acromegaly
- (2016) Luiz Eduardo Wildemberg et al. EXPERT OPINION ON PHARMACOTHERAPY
- Cabergoline in acromegaly
- (2016) Emmanuelle Kuhn et al. Pituitary
- Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study
- (2016) Marcello D. Bronstein et al. BMC Endocrine Disorders
- AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: MANAGEMENT OF ACROMEGALY PATIENTS: WHAT IS THE ROLE OF PRE-OPERATIVE MEDICAL THERAPY?
- (2015) Maria Fleseriu et al. Endocrine Practice
- Novel Techniques in the Surgical Treatment of Acromegaly: Applications and Efficacy
- (2015) Michael Buchfelder et al. NEUROENDOCRINOLOGY
- The Role of Radiotherapy in Acromegaly
- (2015) Mark J. Hannon et al. NEUROENDOCRINOLOGY
- Long-Term Efficacy and Safety of Pegvisomant in Combination With Long-Acting Somatostatin Analogs in Acromegaly
- (2014) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Somatostatin analogs: does pharmacology impact antitumor efficacy?
- (2014) Mounira Chalabi et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
- (2014) Mônica R Gadelha et al. Lancet Diabetes & Endocrinology
- Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study
- (2013) Astrid Breitschaft et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly - 2011 Update: Executive Summary
- (2013) Laurence Katznelson et al. Endocrine Practice
- Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naïve patients with somatotroph adenomas
- (2013) Sarah Larkin et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
- (2013) Philippe J. Caron et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly
- (2012) Patrick Petrossians et al. ANNALES D ENDOCRINOLOGIE
- Immunoreactivity Score Using an Anti-sst2A Receptor Monoclonal Antibody Strongly Predicts the Biochemical Response to Adjuvant Treatment with Somatostatin Analogs in Acromegaly
- (2012) Federico Gatto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Management Options for Persistent Postoperative Acromegaly
- (2012) Nestoras Mathioudakis et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Novel pathway for somatostatin analogs in patients with acromegaly
- (2012) Mônica R. Gadelha et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Resistance to Somatostatin Analogs in Acromegaly
- (2011) Annamaria Colao et al. ENDOCRINE REVIEWS
- Combination treatment with somatostatin analogues and pegvisomant in acromegaly
- (2011) S.J.C.M.M. Neggers et al. GROWTH HORMONE & IGF RESEARCH
- Place of Cabergoline in Acromegaly: A Meta-Analysis
- (2011) Laure Sandret et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mortality in Patients with Pituitary Disease
- (2010) Mark Sherlock et al. ENDOCRINE REVIEWS
- Impact of gsp Oncogene on the mRNA Content for Somatostatin and Dopamine Receptors in Human Somatotropinomas
- (2010) Giselle Fernandes Taboada et al. NEUROENDOCRINOLOGY
- At-risk for pathological gambling: imaging neural reward processing under chronic dopamine agonists
- (2009) Birgit Abler et al. BRAIN
- A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long-acting octreotide in patients with acromegaly
- (2009) Peter J. Trainer et al. CLINICAL ENDOCRINOLOGY
- ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
- (2009) M. Sherlock et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly pathogenesis and treatment
- (2009) Shlomo Melmed JOURNAL OF CLINICAL INVESTIGATION
- Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant
- (2008) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy
- (2008) Diego Ferone et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started